News & Events
Insight Genetics to Present New Data on Subtyping Ovarian Cancer at 2015 American Society of Clinical Oncology Annual Meeting
Insight Genetics will present new data on classifying distinct molecular subtypes of serous ovarian cancer at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.
Insight Genetics' Collaborator Publishes Article in Cancer Advocacy Coalition of Canada’s Annual Report Card on Cancer
Insight Genetics’ collaborator from the British Columbia Cancer Agency, Dr. David Saltman, recently published an article that appears in Cancer Advocacy Coalition of Canada’s Annual Report Card on Cancer.
Biocept and Insight Genetics Collaborate to Advance Non-Small Cell Lung Cancer Diagnosis and Treatment
Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs); and Insight Genetics, a leading molecular diagnostic assay development company, today announced their collaboration to generate an enhanced diagnostic for the expression and mutation of ALK, a major therapeutic target in the treatment of non-small cell lung cancer.